Lung stem cells (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
85 | Idiopathic interstitial pneumonia | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02745184 (ClinicalTrials.gov) | April 2016 | 15/4/2016 | Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis | Idiopathic Pulmonary Fibrosis | Biological: Lung stem cells | Shanghai East Hospital | Regend Therapeutics | Recruiting | 40 Years | 75 Years | All | 20 | Phase 1;Phase 2 | China |